Early detection, innovative drugs and a better understanding of lung cancer is resulting in improved outcomes for people with the disease.
27 May 2026
Early detection, innovative drugs and a better understanding of lung cancer is resulting in improved outcomes for people with the disease.
By
Herb Brody0
Herb Brody
Newly developed drug helps extend the lives of lung cancer patients in trial
New drug a ‘promising step forward’ for hard-to-treat lung cancer
Groundbreaking urine test could detect lung cancer years before symptoms appear
Summit, Akeso drug reduces death by 34% in China lung cancer study. Here’s what it means
A hotly debated lung cancer drug cut the risk of death by 34% in a late-stage trial in China
‘Silent killer’: the race to beat cancer in Hong Kong
At ASCO, positive data for Bristol in multiple myeloma and Pfizer in lung cancer
Akeso and Summit’s ivonescimab extends survival in squamous cell lung cancer
Is Hong Kong winning the war on cancer or facing new front in late diagnosis?
Cancer breakthrough as new 'game-changing' pill could double survival time
A molecular signature can identify those most at risk
